Christine Chevreau

4PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 12, 2024
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.

Justine Gantzer, Maud Toulmonde, François Severac

|Mar 06, 2021
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.

Christine Chevreau, Christophe Massard, Aude Flechon

|Jul 17, 2020
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.

Robert J Motzer, Bernard Escudier, Saby George

|Mar 05, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Lorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay

Pageof 1

Frequent Collaborators

2 joint publications

Jean-Yves Blay

1 joint publications

Lorenzo D'Ambrosio

1 joint publications

Giovanni Grignani

1 joint publications

Silvia Stacchiotti